Remarkably, a recent report showed that ISRIB (integrated stress response inhibitor), a small molecule that reverses the effects of eIF2α phosphorylation downstream of PERK, reduces the abundance of the PD-L1 protein in murine MYCTg;KRASG12D liver cancer cells [51]. The gene discussed is EIF2A; the disease is liver cancer.